The present invention provides the use of escin for the manufacture of a pharmaceutical preparation for the treatment diseases mediated or caused by activated granulocytes, preferably a type I or type III allergy or septic shock.
A61K 31/704 - Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin, digitoxin
A61K 36/77 - Sapindaceae (Soapberry family), e.g. lychee or soapberry
A61K 9/00 - Medicinal preparations characterised by special physical form
01 - Chemical and biological materials for industrial, scientific and agricultural use
03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
05 - Pharmaceutical, veterinary and sanitary products
42 - Scientific, technological and industrial services, research and design
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Chemical compositions and materials for use in cosmetics; Chemical compositions and materials for use in science; Activators [chemicals]; Biochemicals for use as indicators [other than for medical use]; Biochemical preparations other than for medical use; Biochemical substances [other than for medical use]; Biological preparations, other than for medical or veterinary purposes; Biological preparations [other than for medical use]; Biological substances [other than for medical or veterinary use]; Chemicals for use in analysis [other than medical and veterinary]; Chemical preparations for use in the manufacture of pharmaceuticals; Chemical emulsifiers; Chemical substances for analyses in laboratories, other than for medical or veterinary purposes; Chemical products for biotechnological purposes [industrial]; Chemicals for treating spent chemicals used in manufacture; Chemicals for use in industry and science; Chemical products for the preparation of odorous products; Chemicals for use in the pharmaceutical industry; Chemical products for the manufacture of toilet preparations; Chemical products for the preparation of perfumes; Chemical products for preserving products during storage; Chemical substances for analysis in laboratories; Chemical substances for use in the biochemical industry; Chemical substances for use in the production of drugs; Chemical substances for use in the manufacture of scented cosmetics; Chemical substances for modifying the properties of polymers; Chemical substances for use in the manufacture of perfumes; Chemical compositions for absorbing hydrocarbons; Chemical additives; Additives (Chemical -) for use in enzyme stabilisation; Dispersing agents; Emulsifiers for solvents; Emulsifiers for industrial purposes; Emulsifying preparations; Emulsifiers; Enzyme stabilizers; Sequestrating agents; Preservatives for pharmaceutical preparations; Preservatives for use in the pharmaceutical industry; Solvents for use in manufacturing processes; Diluents for industrial use; Solvents for industrial use in manufacturing operations; Solvents for use in industrial manufacturing processes; Chemical reagent mixtures, other than for medical or veterinary use; Surface-active chemical agents; Reagents for use in analysis [other than for medical or veterinary purposes]; Reagents for chemical analyses; Reagents for scientific or medical research use; Reagents for use with analyzers [other than for medical or veterinary purposes]; Stabilizing agents for solvents; Substances for laboratory use; Detergents for use in manufacturing processes; Detergents for industrial use; Detergents for industrial use as part of manufacturing operations. Cosmetics and cosmetic preparations; Body cleaning and beauty care preparations; Oral hygiene preparations; Cosmetics for personal use; Perfumed lotions [toilet preparations]; Perfumed body lotions [toilet preparations]; Toiletries. Eye drops; Analeptics; Analgesics; Topical analgesics; Allergy medication; Antibiotics; Anaesthetics; Anti-viral agents; Medicine; Medicines for human purposes; Medicines for veterinary purposes; Medicines for dental purposes; Eye lotions for medical use; Balms for pharmaceutical purposes; Balms for medical purposes; Chemico-pharmaceutical preparations; Chemical preparations for pharmaceutical purposes; Anti-inflammatories; Hormone preparations for pharmaceutical use; Immunomodulators; Vaccine adjuvants; Inhalants; Inhalant anesthetics; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Local anesthetics; Topical analgesic creams; Lotions for pharmaceutical purposes; Solutions for medical use in washing the nasal passages; Medicated lotions; Medicated mouth spray; Medicated nasal spray preparations; Medicated throat sprays; Medicinal preparations and substances; Anti-malarials; Preparations for ocular lubrication; Mouth sprays for medical use; Mouthwashes [gargles] for medical purposes; Nasal cleaning preparations for medical purposes; Nasal sprays for medical purposes; Nasal spray for the treatment of allergies; Nasal rinse; Nose drops; Nasal drops for the treatment of allergies; Nicotine gum for use as an aid to stop smoking; Ophthalmologic preparations; Oral analgesics; Ocular pharmaceuticals; Pharmaceutical drugs; Pharmaceutical preparations for human use; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations; Pharmaceutical preparations and substances with analgesic properties; Pharmaceutical preparations and substances with anti-inflammatory properties; Non-prescription medicines; Tobacco substitutes for medical purposes; Diagnostic preparations; Pharmaceuticals and natural remedies; Breath refreshers for medical purposes; Biochemical preparations for medical use; Biochemical preparations for veterinary use; Chemical preparations for medical purposes; Chemical preparations for veterinary purposes; Detergents for medical purposes; Diagnostic agents for medical use; Diagnostic preparations for veterinary purposes; Lotions for veterinary purposes; Medical preparations; Pharmaceutical preparations for animals; Pharmaceutical preparations for veterinary use; Tobacco-free cigarettes for medical purposes; Dental anaesthetics; Medicated mouth care preparations; Medicated mouth treatment preparations; Medicated mouthwash; Pharmaceutical preparations for dental use; Eye-washes; Chemical preparations for sanitary purposes; Sanitary preparations for medical purposes. Science and technology services; Medical and pharmacological research services; Natural science services; Advisory services relating to scientific research; Consultancy services relating to technological research; Providing information about industrial analysis and research services; Research laboratories; Chemical engineering; Technical research projects and studies; Laboratory testing; Scientific testing services; Development of new products; Drug discovery services; Research and development services in the field of antibodies; Cosmetic research; Research and development in the field of biotechnology; Industrial analysis and research services in the field of chemistry; Laboratory services for analytical testing; Advisory services relating to science; Scientific research and analysis; Scientific laboratory services. Pharmaceutical services.
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Disinfectants and antiseptics; Chemical preparations for sanitary purposes; Hygienic preparations for veterinary use; Sanitary preparations for medical purposes; Sanitary towels; Sanitary tampons; Panty liners; Pantyliners; Absorbent sanitary articles; Sanitary wear; Alginates for pharmaceutical purposes; Anti-allergy sprays; Allergy medication; Antibiotics for human use; Antibiotics for veterinary use; Antibiotic creams; Antibiotic ointments; Mixed antibiotic preparations; Antibiotics in the form of lotions; Antibiotic tablets; Anti-microbial preparations; Anti-viral agents; Medicines for human purposes; Medicines for veterinary purposes; Allergy relief medication; Eye lotions for medical use; Eye ointment for medical use; Chemico-pharmaceutical preparations; Chemicals for pharmaceutical use; Chemical preparations for pharmaceutical purposes; Elixirs for relieving chills; Elixirs for preventing chills; Elixirs for relieving asthma; Elixirs for preventing throat infections; Elixirs [pharmaceutical preparations]; Anti-inflammatory gels; Anti-inflammatory preparations; Anti-inflammatory ointments; Anti-inflammatory sprays; Moist wipes impregnated with a pharmaceutical lotion; Throat lozenges; Hand creams for medical use; Vaccines against flu; Vaccine adjuvants; Anti-infective products for veterinary use; Topical anti-infective substances for the treatment of infections of the eye; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalants; Irish moss for medical purposes; Allergy capsules; Chewing gum for medical purposes; Lotions for pharmaceutical purposes; Solutions for medical use in washing the nasal passages; Therapeutic creams [medical]; Medicated lip balm; Medicated lip care preparations; Medicated lotions; Medicated mouth spray; Medicated nasal spray preparations; Medicated lozenges; Medicinal preparations for the treatment of infectious diseases; Medicinal preparations and substances; Medicated throat sprays; Medicinal sprays; Impregnated pads containing medicated preparations; Preparations for ocular lubrication; Cold sore treatment preparations; Mouth sprays for medical use; Mouthwashes [gargles] for medical purposes; Nasal sprays for medical purposes; Nasal spray for the treatment of allergies; Nasal rinse; Nose drops; Nasal drops for the treatment of allergies; Topical ophthalmic anti-infective substances for the treatment of infections; Ophthalmologic preparations; Lozenges for pharmaceutical purposes; Plant and herb extracts for medicinal use; Plant extracts for pharmaceutical purposes; Ocular pharmaceuticals; Pharmaceutical drugs; Pharmaceutical creams; Pharmaceutical cold preparations; Pharmaceutical antiallergic preparations and substances; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis; Pharmaceutical lipsalves; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for human use; Pharmaceutical preparations for treating asthma; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations and substances with anti-inflammatory properties; Pharmaceutical preparations and substances with antipyretic properties; Pharmaceutical preparations and substances with analgesic properties; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for the prevention of inflammatory disorders; Pharmaceutical preparations for the prevention of diseases of the respiratory system; Pharmaceutical preparations for the prevention of disorders caused by bacteria; Pharmaceutical preparations for the prevention of allergies; Pharmaceutical preparations for the prevention of ocular disorders; Pharmaceutical preparations for the prevention of inflammatory diseases; Pharmaceutical preparations for the prevention of diseases caused by bacteria; Pharmaceutical preparations for the prevention of ocular diseases; Pharmaceutical preparations for the prevention of disorders of the respiratory system; Pharmaceutical preparations for inhalers; Preparations for the treatment of asthma; Compounds for treating respiratory diseases; Preparations for treating colds; Medicine cases, portable, filled; Non-prescription medicines; Ointments for pharmaceutical purposes; Decongestant nasal sprays; Tinctures for medical purposes; Transdermal patches for medical treatment; Tissues impregnated with pharmaceutical lotions; Viral vaccines; Virucides; Antiseptic cotton; Aseptic cotton; Eye bandages for medical use; Cotton for medical use; Adhesive plasters; Adhesive bandages; Sticking plasters for medical use; Impregnated antiseptic wipes; Impregnated medicated swabs; Medicated plasters; Impregnated medicated pads; Moist paper hand towels impregnated with a pharmaceutical lotion; Plasters, materials for dressings; Cotton wool for medical use; Tampons for medical purposes; Transdermal patches; Dressings, medical; Cotton wool for pharmaceutical purposes; Wadding for medical purposes; Eye drops; Biochemical preparations for medical use; Biochemical preparations for veterinary use; Biological preparations for medical purposes; Biological preparations for veterinary purposes; Chemical preparations for medical purposes; Chemical preparations for veterinary purposes; Antipyretic preparations; Impregnated medicated wipes; Capsules for medicines; Cachets for pharmaceutical purposes; Lotions for veterinary purposes; Microbicides; Pharmaceutical preparations for veterinary use; Oral vaccine preparations; Portable first-aid kits; Sanitary preparations for veterinary use; Antimicrobial mouthwashes; Antiseptic mouthwashes; Medicated mouth care preparations; Medicated mouth treatment preparations; Medicated dental rinses; Medicated mouthwash; Mouthwashes for medical purposes; Pharmaceutical preparations for dental use.
The present invention relates to iota- and/or kappa-carrageenan in combination with a neuraminidase inhibitor for use as a medicament in the prophylactic or therapeutic treatment of a symptom, condition or disease caused by or associated with an infection by an influenza virus.
A61K 31/715 - Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkagesDerivatives thereof, e.g. ethers, esters
The present invention relates to novel inhibitors of neuraminidase for use as a medicament in the prophylactic or therapeutic treatment of a symptom, condition or disease caused by or associated with an infection or co-infection by a virus having neuraminidase (NA) activity, particularly of the orthomyxo- or paramyxovirus families.
The present invention relates to iota- and/or kappa-carrageenan in combination with a neuraminidase inhibitor for use as a medicament in the prophylactic or therapeutic treatment of a symptom, condition or disease caused by or associated with an infection by an influenza virus.
The present invention provides the use of escin for the manufacture of a pharmaceutical preparation for the treatment of a Type IV hypersensitivity reaction or symptoms of a Type IV hypersensitivity reaction, such as in contact dermatitis, atopic dermatitis, hypersensitivity pneumonitis, chronic transplant rejection, graft versus host disease, cell mediated autoimmune diseases, Hashimoto's thyroiditis, Sjogren's disease, adrenalitis, polymyositis, or pernicious anemia.
A61K 36/49 - Fagaceae (Beech family), e.g. oak or chestnut
A61K 36/77 - Sapindaceae (Soapberry family), e.g. lychee or soapberry
A61K 31/704 - Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin, digitoxin
A61P 43/00 - Drugs for specific purposes, not provided for in groups
The present invention relates to pharmaceutical compositions based on carrageenan as an active ingredient, for use as a medicament in the prophylactic or therapeutic treatment of allergic conditions or diseases, with the proviso that the carrageenan comprises iota- and/or kappa-carrageenan and is substantially free of lambda carrageenan. Typically, the invention relates to liquid formulations, gels and dry powder compositions comprising iota- and/or kappa-carrageenan and, optionally, one or more non-carrageenan therapeutic agents for administration to the respiratory tract, the gastrointestinal tract or the eyes. The compositions of the invention have been found to be efficacious in the prevention and treatment of type I allergies and additionally, may exert an adjuvant function upon combined mucosal administration with non-carrageenan therapeutic agents.
The present invention provides for the use of iota- and/or kappa-carrageenan for the manufacture of an antiviral pharmaceutical composition for the prophylaxis or treatment of a pathological condition or disease caused by or associated with an infection by a respiratory virus selected from the group consisting of orthomyxovirus, paramyxovirus, adenovirus and coronavirus. The present invention further provides for the use of fucoidan, in particular of high molecular weight fucoidan, for the manufacture of an antiviral pharmaceutical composition for the prophylaxis or treatment of a pathological condition or disease caused by or associated with an infection by a respiratory virus selected from the group consisting of orthomyxovirus and paramyxovirus.
A61K 31/431 - Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula , e.g. penicillins, penems containing further heterocyclic ring systems, e.g. ticarcillin, azlocillin, oxacillin
A61K 31/737 - Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
The present invention provides for the use of iota-, kappa- or lambdacarrageenan or mixtures thereof for the manufacture of an antiviral pharmaceutical composition for the prophylaxis or treatment of a rhinovirus infection.
The present invention provides the use of escin for the manufacture of a pharmaceutical preparation for the treatment diseases mediated or caused by activated granulocytes, preferably a type I or type III allergy or septic shock.
A61K 31/704 - Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin, digitoxin
A61K 36/49 - Fagaceae (Beech family), e.g. oak or chestnut
12.
CELLULOSE SULFATE FOR THE TREATMENT OF RHINOVIRUS INFECTION
The present invention provides the use of a polymer for the manufacture of an antiviral pharmaceutical composition for the treatment of a rhinovirus infection, wherein the polymer is cellulose sulfate.
The present invention provides the use of cellulose sulfate or chitosan for the manufacture of an anti-inflammatory pharmaceutical or cosmetic composition for the treatment of inflammation.
